FIELD: organic chemistry, medicine, virology, pharmacy.
SUBSTANCE: invention relates to using 4'-substituted nucleosides of the formula (I): wherein R means hydrogen atom; R1 means alkyl possibly substituted with hydroxyl, and alkenyl, alkynyl, alkoxy, cyano or azido group; R2 means hydrogen atom or hydroxyl; R3 and R4 mean hydrogen atom, hydroxyl, alkoxy or halogen atom under condition that at least one radical among R3 and R4 means hydrogen atom; B means 9-purinyl residue of the formula (B1): wherein R5 means hydrogen atom; R6 means hydroxyl or -NHR8; R7 means hydrogen atom; R8 means hydrogen atom or phenylcarbonyl; or B means 1-pyrimidinyl residue of the formula (B2): wherein Z means oxygen atom (O); R10 means hydroxyl or -NHR8; R11 means hydrogen atom; R8 means a value given above. Also, invention relates to pharmaceutically acceptable salts of the compounds used for preparing a drug for treatment of diseases mediated by hepatitis C virus (HCV). Also, invention relates to a pharmaceutical composition for preparing a drug used in treatment of diseases mediated by hepatitis C virus (HCV), and to using this pharmaceutical composition for preparing a drug for treatment of diseases mediated by hepatitis C virus (HCV).
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
7 cl, 9 sch, 3 ex
Authors
Dates
2008-04-27—Published
2002-06-07—Filed